Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Read Article
News
2024
2023
Archive
Search news articles
June 11, 2014
PHASE 3 DATA DEMONSTRATE COMPARABILITY OF EPIRUS’ BOW015 TO REMICADE® FOR TREATMENT OF RHEUMATOID ARTHRITIS
May 19, 2014
AUDENTES THERAPEUTICS ANNOUNCES SIX ABSTRACTS TO BE PRESENTED AT THE AMERICAN SOCIETY OF GENE AND CELL THERAPY MEETING MAY 21-24, 2014
May 9, 2014
PAULSON CAPITAL AND VARIATION BIOTECHNOLOGIES ENTER INTO MERGER AGREEMENT
May 1, 2014
CETERIX ANNOUNCES RESULTS FROM BIOMECHANICAL STUDIES OF MINIMALLY INVASIVE ORTHOPAEDIC SUTURING DEVICE
April 30, 2014
FLEXION THERAPEUTICS INITIATES A PHASE 2B CONFIRMATORY DOSE-RANGING TRIAL WITH LEAD COMPOUND FX006
April 16, 2014
EPIRUS CLOSES $36 MILLION SERIES B FINANCING
March 27, 2014
FIERCEBIOTECH: RUIYI BANKS $15M FROM A-LIST BACKERS TO AMP UP CHINESE R&D
March 20, 2014
JOHNSON MATTHEY DAVY TECHNOLOGIES LTD. AND RENNOVIA, INC. TO DEVELOP AND COMMERCIALIZE PRODUCTION TECHNOLOGY FOR BIO-BASED GLUCARIC ACID AND ADIPIC ACID
March 17, 2014
ACHAOGEN ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING AND EXERCISE OF UNDERWRITERS’ OVER-ALLOTMENT OPTION TO PURCHASE ADDITIONAL SHARES
March 13, 2014
NATURE BIOTECHNOLOGY’S ACADEMIC SPINOUTS OF 2013
« Previous Page
1
…
101
102
103
104
105
…
119
Next Page »